CHR d'ORLEANS
Orléans, 45067, France
NCT Number: NCT03095690
Idiopathic Parkinson's disease (IPD) is the second most frequent neurodegenerative disease. Its association with osteroporosis and fragility fracture is now clearly demonstrated, but the determinants of this osteoporosis are yet to be explained. Our aim was to study factors associated with volumetric bone mineral density (vBMD) and bone microstructure at the tibia and radius in IPD.
Looking for future studies?
Notify Me35 year–85 year
All sexes
Interventional
Not applicable
Orléans, 45067, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
radius and tibia osteodensitometry measurement
Time frame: 0 hour
Measurement performed by High Resolution peripheral Quantitative Computed Tomography (HRpQCT)
Centre Hospitalier Régional d'Orléans
Other
Determinants of Volumetric Bone Mineral Density at the Tibia and Radius and it's Relationship With Osteoporotic Fractures in Idiopathic Parkinson's Disease
Acronym: DOPPA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01221948
Basal Ganglia Diseases, Brain Diseases
Vienna, Austria
View Trial DetailsNCT05671341
Basal Ganglia Diseases, Brain Diseases
Niğde, Niğde Province, Turkey (Türkiye)
View Trial DetailsNCT02610231
Basal Ganglia Diseases, Brain Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT01968031
Basal Ganglia Diseases, Brain Diseases
Phoenix, Arizona, United States
View Trial Details